A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema

BACKGROUND: Patients with hereditary angioedema with C1 inhibitor deficiency or dysfunction have burdensome recurrent angioedema attacks. The safety, efficacy, and health‐related quality of life (HRQoL) outcomes of C1 inhibitor (C1‐INH) prophylaxis (intravenously administered) in patients aged 6‐11 ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pediatr Allergy Immunol
Main Authors: Aygören‐Pürsün, Emel, Soteres, Daniel F., Nieto‐Martinez, Sandra A., Christensen, Jim, Jacobson, Kraig W., Moldovan, Dumitru, Van Leerberghe, Arthur, Tang, Yongqiang, Lu, Peng, Vardi, Moshe, Schranz, Jennifer, Martinez‐Saguer, Inmaculada
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6851661/
https://ncbi.nlm.nih.gov/pubmed/30968444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/pai.13060
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados